The iStent platform uses tiny surgical implants to lower eye pressure by restoring the eye’s natural fluid drainage system in patients with glaucoma
Review will evaluate effectiveness in treating alcohol withdrawal syndrome and supporting abstinence, as well as measures to mitigate risk of abuse
The company's decision to withdraw the MAA was due to the timing of the availability of Chemistry Manufacturing and Controls
BRAVE study will explore the potential of omaveloxolone to address the critical unmet need of the pediatric FA population
Innovative agents highlight growth of targeted protein degradation platform and BMS' leadership in innovative cancer therapies
Dilip Shanghvi to continue as the Executive Chairman of the Board
Enhanced alignment to better serve customers across the entire drug development lifecycle under the Fujifilm Life Sciences brand umbrella with the tagline Partners for Life
AMPLIFY Phase III trial results demonstrated statistically significant and clinically meaningful improvement in progression-free survival for Calquence combinations
If approved, linerixibat could address high unmet medical need of patients living with cholestatic pruritus (relentless itch) and related sleep interference
Subscribe To Our Newsletter & Stay Updated
